| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Jul 11, 2024 |
|||||||||
| Q2 FY24 | $2.28 | $2.16 | $22.50B | $22.59B |
NASDAQ |
||||
| Q2 FY24 | $2.36 | $2.36 | $16.66B | $15.45B |
NYSE |
||||
|
Conagra Brands
CAG
|
Q4 FY24 | $0.61 | $0.57 | $2.91B | $2.93B |
NYSE |
|||
|
Methode Electronics
MEI
|
Q4 FY24 | -$0.23 | -$0.21 | $277.30M | $264.04M |
NYSE |
|||
|
Bank7
BSVN
|
Q2 FY24 | $1.23 | $1.04 | $24.40M | $23.30M |
NASDAQ |
|||
|
Northern Technologies International
NTIC
|
Q3 FY24 | $0.11 | $0.24 | $20.69M | $22.50M |
NASDAQ |
|||
|
Nurix Therapeutics
NRIX
|
- | -$0.71 | -$0.66 | $12.09M | $22.10M |
NASDAQ |
|||
|
Educational Development
EDUC
|
Q1 FY25 | -$0.15 | - | $9.99M | - |
NASDAQ |
|||
|
Sono-Tek
SOTK
|
- | $0.02 | $0.01 | $5.03M | $4.81M |
NASDAQ |
|||
|
KalVista Pharmaceuticals
KALV
|
- | -$1.02 | -$0.71 | - | $4.46M |
NASDAQ |
|||
|
Avalo Therapeutics
AVTX
|
- | -$141.14 | - | - | - |
NASDAQ |
|||
| Show 1 more companies | |||||||||
